Clinical Trials Directory

Trials / Completed

CompletedNCT03135756

Mechanisms of Anxiety and Depression Study

Transdiagnostic Endophenotypes of Anxiety and Depression

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
Palo Alto University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Eligible participants will come in for three separate visits in which they will be interviewed, perform a variety of tasks, and undergo a non-invasive MRI scan. The investigators anticipate that (1) participants with anxiety and depression will likely perform differently than the healthy controls on cognitive tasks, (2) participants with anxiety and depression will likely show differences in brain functionality compared to the healthy controls, and (3) depression and anxiety likely share some underlying mechanisms.

Detailed description

In order to determine eligibility, a brief phone screen lasting approximately 15 minutes will be conducted. If participants are eligible, they will be asked to come in for three separate visits. During the first visit, participants will complete questionnaires as well as a structured interview with one of the study's staff members at Palo Alto University in Los Altos. During the second visit, participants would come to Palo Alto University in Los Altos and complete questionnaires as well as a testing session involving various tasks. During the third visit, participants would undergo a non-invasive brain scan in which participants would complete a task as well as various questionnaires at Stanford University in Stanford. The investigators have flexible hours and can work around participants' schedules! To inquire more about participation, participants can either email the investigators at paloalto.study@gmail.com or call the investigators at (650) 417-2000 ext. 3642

Conditions

Timeline

Start date
2015-03-19
Primary completion
2018-03-14
Completion
2018-03-14
First posted
2017-05-01
Last updated
2018-05-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03135756. Inclusion in this directory is not an endorsement.